Home LiteratureArticle Details
PMID: 26752406 Published · ppublish English Case Reports Letter

Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection.

Alhamad T, Venkatachalam K, Linette GP, Brennan DC

Abstract

暂无摘要

MeSH Terms
Aged Antineoplastic Agents/therapeutic use CTLA-4 Antigen/antagonists & inhibitors Graft Rejection/etiology Graft Survival Humans Kidney Failure, Chronic/complications,surgery Kidney Transplantation/adverse effects Male Melanoma/drug therapy,etiology,secondary Postoperative Complications Prognosis Programmed Cell Death 1 Receptor/antagonists & inhibitors Risk Factors Skin Neoplasms/drug therapy,etiology,pathology Transplant Recipients
Chemicals
Antineoplastic Agents CTLA-4 Antigen PDCD1 protein, human Programmed Cell Death 1 Receptor
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Alhamad T
Renal Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO. | Transplant Epidemiology Research Collaboration (TERC), Institute of Public Health, Washington University in St. Louis, St. Louis, MO.
Venkatachalam K
Renal Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO.
Linette G P
Division of Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO.
Brennan D C
Renal Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO.
Article Info
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Abbr.
Am J Transplant
ISSN
1600-6143
Published
2016-04-00
Epub
2016-00-01
Pages
1332-3
Language
English
Region
United States
NLM ID
100968638
Subset
IM
Grants
NCI NIH HHS · R21 CA205794 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com